Clinical Trial Market Research Reports & Industry Analysis
Clinical Trial Industry Research & Market Reports
-
Endometriosis - Global Clinical Trials Review, 2024
... the clinical trials on Endometriosis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 ... Read More
-
Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast Cancer) - Global Clinical Trials Review, 2024
... - Global Clinical Trials Review, 2024 provides an overview of Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast Cancer) Clinical trials scenario. This report provides top line data relating to the clinical ... Read More
-
Lupus Nephritis - Global Clinical Trials Review, 2024
... data relating to the clinical trials on Lupus Nephritis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials ... Read More
-
Ewing Sarcoma - Global Clinical Trials Review, 2024
... data relating to the clinical trials on Ewing Sarcoma. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials ... Read More
-
Phenylketonuria (PKU) - Global Clinical Trials Review, 2024
... data relating to the clinical trials on Phenylketonuria (PKU). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials ... Read More
-
Global Clinical Trial Imaging Market Size study & Forecast, by Product and Service (Trial Design Consulting Services, Read Analysis Services, Operational Imaging Services, Imaging Software), by Modality (Magnetic Resonance Imaging, Computed Tomography, Ultrasound, Positron Emission Tomography, X-Ray, Other Modalities), by End-User and Regional Analysis, 2023-2030
... Tomography, X-Ray, Other Modalities), by End-User and Regional Analysis, 2023-2030 Global Clinical Trial Imaging Market is valued at approximately USD 1.13 billion in 2022 and is anticipated to grow with a healthy growth rate of ... Read More
-
Mucopolysaccharidosis II (MPS II) (Hunter Syndrome ) - Global Clinical Trials Review, 2024
... Mucopolysaccharidosis II (MPS II) (Hunter Syndrome ) Clinical trials scenario. This report provides top line data relating to the clinical trials on Mucopolysaccharidosis II (MPS II) (Hunter Syndrome ) . Report includes an overview of ... Read More
-
Cutaneous Squamous Cell Carcinoma (cSCC) - Global Clinical Trials Review, 2024
... (cSCC) Clinical trials scenario. This report provides top line data relating to the clinical trials on Cutaneous Squamous Cell Carcinoma (cSCC). Report includes an overview of trial numbers and their average enrollment in top countries ... Read More
-
Seasonal Influenza - Global Clinical Trials Review, 2024
... data relating to the clinical trials on Seasonal Influenza. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials ... Read More
-
Hemophilia A (Factor VIII Deficiency) - Global Clinical Trials Review, 2024
... Deficiency) Clinical trials scenario. This report provides top line data relating to the clinical trials on Hemophilia A (Factor VIII Deficiency). Report includes an overview of trial numbers and their average enrollment in top countries ... Read More
-
Global In Silico Clinical Trials - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029
... is expected to reach USD 5.08 billion by 2029, growing at a CAGR of 6.89% during the forecast period (2024-2029). The unanticipated spread of COVID-19 significantly influences the in silico clinical trials market. Even though ... Read More
-
Clinical Trial Management Systems - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029
... Key Highlights The COVID-19 pandemic significantly impacted the clinical trial management market. The pandemic restrictions implemented to control the virus's spread disrupted ongoing clinical trials, causing delays and cancellations of trials in the early pandemic ... Read More
-
Pharmaceutical Intermediates - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2021 - 2029
... billion by 2029, growing at a CAGR of 7.42% during the forecast period (2024-2029). COVID-19 pandemic had a significant impact on the market studied. According to a study that was published in the American Chemical ... Read More
-
Clinical Trial Imaging - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2021 - 2029
... USD 1.63 billion by 2029, growing at a CAGR of 5.38% during the forecast period (2024-2029). Clinical trials are used in the development and testing of vaccines and other therapeutics; they have been essential in ... Read More
-
Clinical Trials - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029
... billion by 2029, growing at a CAGR of 5.91% during the forecast period (2024-2029). The COVID-19 pandemic tremendously impacted the market for clinical trials, as there has been a rising focus on developing new therapeutics ... Read More
-
Global Virtual Clinical Trials - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029
... to reach USD 14.88 billion by 2029, growing at a CAGR of 9.34% during the forecast period (2024-2029). The COVID-19 pandemic has shut down population movements and transport systems across large parts of the world, ... Read More
-
STXBP1 Encephalopathy
... overview, epidemiology (US and EU5), current treatment, unmet needs, pipeline and access and reimbursement chapter. Topics covered in this report: • Disease overview: Review the disease pathophysiology and potential druggable targets • Epidemiology: Understand prevalence, ... Read More
-
Innovation Waves in Immuno-oncology Therapy Development
... prevalence of various types of aggressive and refractory cancers, the next-generation I-O therapy pipeline has witnessed significant growth. Chimeric antigen receptor (CAR)-T cell therapy and tumor-targeted antibody therapies, including monoclonals, antibody-drug conjugates (ADCs), bispecific antibodies, ... Read More
-
Premature Labor (PL) -Competitive Landscape
... the 16 countries covered in GlobalData’s epidemiology forecast for PL. Marketed drugs for PL are widely genericized and the majority of drugs indicated to treat PL are beta-2 adrenergic receptor antagonists. Out of 13 drugs ... Read More
-
Asia CRO Market Research Report Forecast to 2032
... development are boosting the demand for CRO services. Moreover, the rising prevalence of chronic diseases and government support for R&D are also fueling the growth of the market. However, a lack of experienced and skilled ... Read More
-
Angelman Syndrome
... overview, epidemiology (US and EU5), current treatment, unmet needs, pipeline and access and reimbursement chapter. Topics covered in this report: • Disease overview: Review the disease pathophysiology and potential druggable targets • Epidemiology: Understand prevalence, ... Read More
-
Global Clinical Trial Software Market Professional Survey by Types, Applications, and Players, with Regional Growth Rate Analysis and Development Situation, from 2023 to 2028
... growth of the Clinical Trial Software industry between the year 2018 to 2028, and breaks down according to the product type, downstream application, and consumption area of Clinical Trial Software. The report also introduces players ... Read More
-
Clinical Trials Market, Size, Global Forecast 2024-2030, Industry Trends, Share, Growth, Insight, Impact of Inflation, Company Analysis
... Renub Research. Clinical trials have been a part of the medical outlook for 275 years, creating opportunities for physicians to find viable treatments for various conditions. These are studies to test new drugs, already-approved drugs, ... Read More
-
Global Anticancer Drugs Market Research Report 2024
... during the forecast period 2024-2030. North American market for Anticancer Drugs is estimated to increase from $ 104,835 million in 2023 to reach $ 207,068 million by 2030, at a CAGR of 10.7% during the ... Read More
-
Giant-Cell Arteritis - Market Insight, Epidemiology And Market Forecast - 2034
... originates from melanocytes, pigment-producing cells, and can potentially metastasize, commonly to the liver. Ocular melanoma can be divided into uveal and non-uveal melanoma. Uveal melanoma (~95%) comprises the larger group of ocular melanoma and consists ... Read More
Research Assistance
